Bioinformatics

Digitisation in the field of Life Science

In bioinformatics, the multifaceted field of life science meets the analytical problem-solving approaches applied in computer science.

A broad understanding of chemistry, biochemistry, biology, medicine and pharmacology is necessary in bioinformatics to create solutions that are data intensive and highly complex. Computer science provides the software tools to transform these approaches into usable results.

In recent years, bioinformatics has been the only way to gain far-reaching insights into:

  • Genomes and proteomes,
  • Gene and protein expression and regulation,
  • Metabolic and regulatory, signal transduction and networks,
  • Structures of biomacromolecules, especially DNA, RNA, and proteins,
  • Interactions between biomacromolecules with one another and between  biomacromolecules and other substances, such as messenger substances and inhibitors, at a molecular and atomic level.

The patenting of algorithms and methods from the field of bioinformatics also brings with it a number of challenges. For example, both the German Patent Act and the European Patent Convention exclude the patenting of abstract algorithms as such. On the diagnostics side, the legislation wants to give the treating physician maximum freedom and restricts the patenting of diagnostic methods. 

To patent your inventions in this field, Meissner Bolte works with an interdisciplinary team of computer scientists and (bio)chemists. The team includes Dr. Bischoff, who studied chemistry and biochemistry, and Mr. Würmser, who studied computer science and has had a special interest in the field of bioinformatics since his studies began.

Mr. Würmser delivers lectures at the European Conference on Computational Biology and advises small and medium-sized companies in the bioinformatics sector on effective measures to protect their intellectual property.

During his doctorate, Dr. Bischoff worked on the computer-based reconstruction of three-dimensional structures of biomacromolecules and their interaction partners. Today he is very active as a patent attorney in the field of life science.